Acute Colonic Necrosis Associated with Sodium Polystyrene Sulfonate (Kayexalate) Enemas in a Critically Ill Patient: Case Report and Review of the Literature

2001 ◽  
Vol 51 (2) ◽  
pp. 395-397 ◽  
Author(s):  
Frederick B. Rogers ◽  
Shuan C. Li
2019 ◽  
Vol 45 (3) ◽  
pp. 570-572
Author(s):  
Stefania Capra ◽  
Sujita W. Narayan ◽  
Kaitlyn Parratt ◽  
Asad E. Patanwala

2020 ◽  
Vol 2 (11) ◽  
pp. 2445-2447
Author(s):  
Heidi Angela Fernandez ◽  
Martín Lescano Ruiz ◽  
Stephanie González Jara

2021 ◽  
pp. 878-883
Author(s):  
Neethi Dasu ◽  
Yaser Khalid ◽  
Kirti Dasu ◽  
Lucy Joo ◽  
Brian Blair

Kayexalate has been used in the USA since 1975 for the treatment of hyperkalemia. Prior case reports have shown that sorbitol added to kayexalate has been known to cause rare side effects of colonic necrosis. We present a unique case report of gastric pneumatosis as a complication of kayexalate.


Author(s):  
Carlos Rubiano ◽  
Kathleen Tompkins ◽  
Subhashini A Sellers ◽  
Brian Bramson ◽  
Joseph Eron ◽  
...  

Abstract We present a case of a critically ill patient with COVID-19 found to have AIDS and Pneumocystis jirovecii pneumonia (PCP). COVID-19 and PCP co-occurrence is increasingly reported and may complicate diagnostic and therapeutic strategies. Patients with severe COVID-19 should be screened for underlying immunocompromise and coinfections should be considered.


2021 ◽  
pp. 194187442110043
Author(s):  
Henly Hewan ◽  
Annie Yang ◽  
Aparna Vaddiparti ◽  
Benison Keung

In late 2019, the novel coronavirus, SARS-CoV-2, and the disease it causes, COVID-19, was identified. Since then many different neurological manifestations of COVID-19 have been well reported. Movement abnormalities have been rarely described. We report here a critically ill patient with COVID-19 who developed generalized myoclonus during the recovery phase of the infection. Myoclonus was associated with cyclical fevers and decreased alertness. Movements were refractory to conventional anti-epileptic therapies. There was concern that myoclonus could be part of a post-infectious immune-mediated syndrome. The patient improved fully with a 4-day course of high-dose steroids. Our experience highlights a rare, generalized myoclonus syndrome associated with COVID-19 that may be immune-mediated and is responsive to treatment.


2017 ◽  
Vol 97 ◽  
pp. 755.e5-755.e10 ◽  
Author(s):  
Lain Hermes Gonzalez-Quarante ◽  
Carlos Fernández Carballal ◽  
Vijay Agarwal ◽  
Antonio J. Vargas Lopez ◽  
Oscar Lucas Gil de Sagredo del Corral ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document